<DOC>
	<DOCNO>NCT00446641</DOCNO>
	<brief_summary>This study recruit 316 ischemic stroke patient take aspirin . They randomly assign cilostazol group placebo group . Every patient take 200mg cilostazol day placebo 1 month . The primary outcome variable study rate biochemical aspirin resistance Ultra Rapid Platelet Function Assay-ASA .</brief_summary>
	<brief_title>Overcome Biochemical Aspirin Resistance Through Cilostazol Combination</brief_title>
	<detailed_description>[ Goal ] To reveal effect safety additional cilostazol overcome biochemical aspirin resistance . [ Trial Design ] Double-Blind , Placebo-Controlled , Randomized , Multicenter Trial [ Participants ] Ischemic stroke patient take aspirin [ Methods ] - Double-Blind , Placebo-Controlled , Randomized , Multicenter Trial - Investigational product : Cilostazol 200mg ( 100mg twice per day ) - Concomitant medication : Aspirin 100 mg per day - Medication Duration : 1 month [ Outcome Variables ] Primary Outcome Variable : • proportion patient aspirin reaction unit ( ARUs ) value ≥550 Ultra Rapid Platelet Function Assay-ASA Secondary outcome variable : - proportion patient ARUs value ≥500 Ultra Rapid Platelet Function Assay-ASA - ARUs value - Bleeding time ( BT ) - Fatal major bleed complication - Any bleeding complication</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Symptomatic cerebral infarction document MRI CT More 35 year age Patients take aspirin 100mg day 2 week randomization Patients take antiplatelets aspirin within 2 week randomization Patients take anticoagulant within 2 week randomization Patients take thrombolytic therapy within 2 week randomization Patients take NSAIDs within 2 week randomization Patients need take NSAIDs regularly ( e.g . rheumatic arthritis ) . Bleeding diathesis Chronic liver disease ( ALT &gt; 100 AST &gt; 100 ) chronic renal disease ( creatinine &gt; 3.0mg/dl ) Anemia ( hemoglobin &lt; 10mg/dl ) thrombocytopenia ( platelet count le 100,000/mm3 ) Pregnant lactate patient Patients schedule angioplasty revascularization procedure within 4 week Patients schedule surgery invasive procedure within 4 week Patients acute coronary syndrome</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Infarction , Cerebral</keyword>
	<keyword>Cilostazol</keyword>
	<keyword>Aspirin Resistance</keyword>
</DOC>